The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Use of PD-1 pathway inhibitors among patients with non-small cell lung cancer (NSCLC) and preexisting autoimmune disorders.
 
Giulia Costanza Leonardi
No Relationships to Disclose
 
Justin F. Gainor
Honoraria - ARIAD; Incyte; Merck
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech; Loxo; Novartis; Theravance
Research Funding - Adaptimmune; ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech; Merck; Novartis
Travel, Accommodations, Expenses - Affymetrix
 
Roxana S. Azimi
No Relationships to Disclose
 
Jonathan Riess
Honoraria - Roche/Genentech
Consulting or Advisory Role - ARIAD; Celgene; Clovis Oncology; Medtronic
Research Funding - Merck (Inst); Millennium (Inst); Novartis (Inst); Onconova Therapeutics
Travel, Accommodations, Expenses - Celgene; Roche/Genentech
 
Hira Rizvi
No Relationships to Disclose
 
Matthew David Hellmann
Consulting or Advisory Role - AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Janssen; Merck; Novartis
Research Funding - Bristol-Myers Squibb; Genentech/Roche
 
Mark M. Awad
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Foundation Medicine; Genentech; Merck; Nektar; Pfizer